The earliest published evidence in support of the hypothesis that ligands targeting TSPO could be used to detect and grade human brain tumors emerged more than twenty years ago [11–13], easily predating molecular studies seeking to elucidate potential roles of TSPO function in tumorigenesis [9, 14, 15]. Here, TSPO is linked to brain neoplasm.